source
- Atossa Therapeutics CEO Steven Quay likely to become NIAID directorSteven Quay, founder and CEO of Atossa Therapeutics, is reported to be the likely choice for director of NIH's National Institute of Allergy and Infectious Diseases. The report notes his backgroun…
- Fujifilm Biotechnologies appoints COO Maja Pedersen as new president after Lars Petersen steps downFujifilm Biotechnologies announced that its chief executive officer and president, Lars Petersen, has stepped down effective immediately. The company said the transition will be seamless as the cur…